Donald W. Kufe serves as Executive at SYNTA PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Donald W. Kufe has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 1, 2013 involved receiving (via award) 8,000 shares valued at $0.
Donald W. Kufe currently holds 25,748 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald W. Kufe has been a net neutral trader of SNTA stock. They have purchased $0 and sold $0 worth of shares.
Donald W. Kufe's most recent insider trade was on Jul 1, 2013, when they sold 8,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.60 |
| Discretionary |
| Jul 25, 2012 | SNTA | $30.0K | Award | 4,622 | $6.49 | Discretionary |
| Jul 1, 2012 | SNTA | $0 | Award | 7,312 | $N/A | Discretionary |